Related Experiment Video
Updated: May 3, 2026
10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
30.6K
Intravitreal bevacizumab injection in unrecognised early pregnancy
L Sullivan1, S P Kelly2, A Glenn3
1Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Eye (London, England)
|January 18, 2014
Summary
Intravitreal vascular endothelial growth factor (VEGF) inhibitors like bevacizumab given in early pregnancy show uncertain safety. Further research is needed to determine risks for fetal development during this critical period.
Area of Science:
- Ophthalmology
- Reproductive Medicine
- Pharmacology
Background:
- Intravitreal anti-VEGF medications are increasingly used in women of reproductive age.
- Bevacizumab is a common intravitreal vascular endothelial growth factor (VEGF) inhibitor.
